Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Finkelstein

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|April 19, 2007
FDA clarifies rules for getting experimental drugsJoel B Finkelstein
Journal of the National Cancer Institute|June 8, 2006
Life insurance: coming to a cancer survivor near youJoel B Finkelstein
Journal of the National Cancer Institute|April 6, 2006
In U.S., biosimilars still await FDA decisionJoel B Finkelstein
Journal of the National Cancer Institute|April 6, 2006
FDA advisory panel voices persistent safety concernsJoel B Finkelstein
Journal of the National Cancer Institute|March 4, 2008
Members of new FDA board tied to industryJoel B Finkelstein
Radiologic Clinics of North America|December 1, 1970
Osteosarcoma of the jaw bonesJ B Finkelstein
Journal of the National Cancer Institute|February 22, 2007
Screening program serves fraction of those eligibleJoel B Finkelstein
Journal of the National Cancer Institute|August 3, 2006
Senate health plan legislation opposed by ACSJoel B Finkelstein
Antonie Van Leeuwenhoek|January 1, 1987
Improvement of enzyme production in AspergillusD B Finkelstein
Journal of the National Cancer Institute|November 15, 2007
Researchers hope state stem cell efforts lastJoel B Finkelstein
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|April 19, 2007
FDA clarifies rules for getting experimental drugsJoel B Finkelstein
Journal of the National Cancer Institute|June 8, 2006
Life insurance: coming to a cancer survivor near youJoel B Finkelstein
Journal of the National Cancer Institute|April 6, 2006
In U.S., biosimilars still await FDA decisionJoel B Finkelstein
Journal of the National Cancer Institute|April 6, 2006
FDA advisory panel voices persistent safety concernsJoel B Finkelstein
Journal of the National Cancer Institute|March 4, 2008
Members of new FDA board tied to industryJoel B Finkelstein
Radiologic Clinics of North America|December 1, 1970
Osteosarcoma of the jaw bonesJ B Finkelstein
Journal of the National Cancer Institute|February 22, 2007
Screening program serves fraction of those eligibleJoel B Finkelstein
Journal of the National Cancer Institute|August 3, 2006
Senate health plan legislation opposed by ACSJoel B Finkelstein
Antonie Van Leeuwenhoek|January 1, 1987
Improvement of enzyme production in AspergillusD B Finkelstein
Journal of the National Cancer Institute|November 15, 2007
Researchers hope state stem cell efforts lastJoel B Finkelstein
Pageof 17